METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

To provide methods for treating Crohn's disease, and in particular, methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor.SOLUTION: A method of inducing clinical remission of Crohn's disease in a patient comprises: a. orally a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AHMAD Y SHEIKH, THOMAS B BORCHARDT, PETER T MAYER, MOHAMED-ESLAM MOHAMED, BEN KLUENDER, MATHEW M MULHERN, JOSE JEFFREY V ENEJOSA, ANNE M ROBINSON, AILEEN L PANGAN, ANA PAULA MACHADO DE LACERDA, AHMED OTHMAN, STEVEN JUNGERWIRTH, ROOPAL B THAKKAR, JAYANTHY JAYANTH, AYMAN D ALLIAN, PATRICK J MARROUM, FREDRIK LARS NORDSTROM
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide methods for treating Crohn's disease, and in particular, methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor.SOLUTION: A method of inducing clinical remission of Crohn's disease in a patient comprises: a. orally administering to the patient an induction dose of upadacitinib or a pharmaceutically acceptable salt thereof, which comprises either 45 mg of upadacitinib or a 45-mg free base equivalent amount of the pharmaceutically acceptable salt thereof, once a day for at least 4 weeks; and b. the patient achieving clinical remission within 12 weeks of administration of the first induction dose.SELECTED DRAWING: None 【課題】JAK1阻害剤を使用してクローン病を処置するための方法、特に、クローン病の臨床的寛解及び/又は内視鏡的改善を誘導するための方法を提供する。【解決手段】患者のクローン病の臨床的寛解を誘導する方法であって、a.45mgのウパダシチニブ、又は45mgの遊離塩基当量の薬学的に許容されるその塩を含む導入用量のウパダシチニブ又は薬学的に許容されるその塩を、患者に、少なくとも4週間、1日1回経口投与することを含み、b.患者が、第1の導入用量の投与後12週以内に臨床的寛解を達成する、方法である。【選択図】なし